NFkappaB modulators in a model of glucocorticoid resistant, childhood acute lymphoblastic leukemia

Leukemia Research
Lindsay NicholsonJulie Irving

Abstract

Glucocorticoids (GCs) are pivotal agents in the treatment of childhood acute lymphoblastic leukaemia (ALL) but the molecular basis of GC-resistance remains unclear. Expression-array studies have shown that commonly upregulated genes associated with GC-sensitivity include GR, glucocorticoid-induced leucine zipper (GILZ) and IkappaBalpha, which all negatively interact with components of the pro-survival NFkappaB pathway and therefore may be critical determinants of GC-sensitivity. We have investigated these regulators and their effect on NFkappaB activity in GC-resistant descendents of the B-lineage ALL cell line, PreB 697. We show that while differential up regulation of the modulators (GILZ, GR and IkappaBalpha) was demonstrated in GC-sensitive compared to GC-resistant sub-lines, this was not coupled with altered nuclear translocation or functionality of the RelA, p50 or c-Rel subunits of NFkappaB. Thus, GC-resistance in the PreB 697 cell line model is not mediated by NFkappaB, however further investigation of the impact of these GC-sensitive associated proteins on other survival pathways, such as the RAS-RAF-MEK-ERK pathway, is warranted.

References

Jan 18, 1994·Proceedings of the National Academy of Sciences of the United States of America·A Ray, K E Prefontaine
Aug 12, 1998·The Journal of Steroid Biochemistry and Molecular Biology·J E BodwellA Munck
Aug 24, 2002·Endocrinology·Yves Le DreanDenis Michel
Mar 22, 2003·British Journal of Haematology·Eric G HaarmanAnjo J P Veerman
Jul 8, 2003·The Journal of Endocrinology·R KoflerM J Ausserlechner
Oct 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jen-Chywan WangKeith R Yamamoto
May 5, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gertjan J L KaspersAnjo J P Veerman
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wim J E TissingRob Pieters
Nov 2, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Stefan SchmidtReinhard Kofler
Dec 28, 2006·Apoptosis : an International Journal on Programmed Cell Death·Ingrid HerrMarkus W Büchler
Aug 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John A MeyersAdam Lerner
Dec 11, 2008·Journal of the National Cancer Institute·Nicolas PottierMeyling H Cheok

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.